Zynlonta savings card: as little as $0 a dose with commercial insurance

Zynlonta is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Zynlonta is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameZynlonta

Authorized genericloncastuximab tesirine

Regular genericloncastuximab tesirine

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Zynlonta?

The original

–

Brand nameThe maker’s card

ADVANCING Patient Support copay program

Savings card from ADC Therapeutics America

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a dose

The card takes up to $25,000 a year off your co-pay.

Or call 1-855-690-0340.

In the maker’s words

“If you are commercially insured and eligible, ADVANCING Patient Support can help your doctor’s office enroll you in the copay program, in which you could pay as little as $0 per dose.”

From the maker’s offer on zynlonta.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Zynlonta itself, from the same company, sold without the brand name, and usually for less. For now Zynlonta is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Zynlonta is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Large B-cell lymphoma after other treatments

What the FDA label says

ZYNLONTA is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low-grade lymphoma, and high-grade B-cell lymphoma.

This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Zynlonta (ADC Therapeutics America, Inc.), June 12, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/zynlonta/